Assessing treatment outcomes of chemoimmunotherapy in extensive-stage small cell lung cancer: an integrated clinical and radiomics approach.
Jie ZhaoYayi HeXue YangPanwen TianLiang ZengKun HuangJing ZhaoJiaqi ZhouYin ZhuQiyuan WangMailin ChenWen LiYi GaoYong-Chang ZhangYang XiaPublished in: Journal for immunotherapy of cancer (2023)
The integrated clinical and radiomics model can predict the treatment outcomes in patients with ES-SCLC receiving chemoimmunotherapy, rendering a convenient and low-cost prognostic model for decision-making regarding patient management.